Fallbericht
Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients with Metastatic Colorectal Cancer: Case Report
The Open Colorectal Cancer Journal · 2010
DOI: 10.2174/1876820201003010023 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Open Colorectal Cancer Journal, 2010. Verfasst von J.M. Zekri und 1 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zekri, J., & Abubacker, M. (2010). Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients with Metastatic Colorectal Cancer: Case Report. The Open Colorectal Cancer Journal. https://doi.org/10.2174/1876820201003010023
Vancouver
Zekri J, Abubacker M. Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients with Metastatic Colorectal Cancer: Case Report. The Open Colorectal Cancer Journal. 2010. doi:10.2174/1876820201003010023
BibTeX
@article{Zekri2010,
author = {Zekri, J.M. and Abubacker, M.Z.},
title = {Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients with Metastatic Colorectal Cancer: Case Report},
journal = {The Open Colorectal Cancer Journal},
year = {2010},
doi = {10.2174/1876820201003010023}
}
EUVIMED